Centene Corp (CNC) Earnings: Company Maintains FY Adjusted EPS Forecast Above $6.80

Centene Corp on Smartkarma

Analysts on Smartkarma, such as Baptista Research, have been closely covering Centene Corporation, a major player in the healthcare industry. In a recent research report titled “Centene Corporation: Medicaid Managed Care Expansion and Optimization! – Major Drivers,” it was noted that Centene has shown a promising financial performance in the first quarter of the year. The company exceeded its anticipated adjusted earnings per share (EPS) at $2.26, leading to an optimistic outlook for the full year 2024 with a forecast of over $6.80 per share. Despite these positive results, analysts highlight both areas of strength and ongoing challenges within the company.

Another report by Baptista Research, “Centene Corporation: Leveraging Dual Eligibles in Medicare and Medicaid & Other Major Drivers,” reiterated the company’s strong performance in the first quarter of 2024. Centene demonstrated strategic maneuvers aimed at enhancing its business operations, resulting in an adjusted EPS of $2.26, surpassing expectations and raising the full-year 2024 EPS guidance to over $6.80. This success has been attributed to notable operational improvements and strategic realignments, setting a positive tone for Centene’s future prospects in the healthcare sector.

A look at Centene Corp Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Centene Corporation, a multi-line managed care organization that focuses on providing Medicaid and Medicaid-related programs, is positioned for a promising long-term outlook based on the Smartkarma Smart Scores. With a strong Value score of 4, Centene appears to offer investors good value relative to its market price. Additionally, the company’s impressive Growth score of 5 suggests a positive outlook for its expansion and revenue potential in the coming years.

While Centene’s Dividend score is lower at 1, indicating a lower emphasis on dividend payouts, its Resilience and Momentum scores sit at 3 each. This signifies a moderate level of resilience in weathering challenges and a steady momentum in performance. Overall, Centene Corporation seems well-positioned for sustained growth and value creation in the healthcare sector.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma